<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02366169</url>
  </required_header>
  <id_info>
    <org_study_id>14-001</org_study_id>
    <nct_id>NCT02366169</nct_id>
  </id_info>
  <brief_title>Medigus Ultrasonic Surgical Endostapler (MUSE) Registry</brief_title>
  <official_title>A Worldwide Post-Market Surveillance Registry to Assess the Medigus Ultrasonic Surgical Endostapler (MUSE™) System for the Treatment of GERD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medigus Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medigus Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry is intended as an observational, post-marketing surveillance tool. The registry
      allows collection of baseline demographics and user experience of the commercially available
      MUSE system. Data collection aims to aggregate a minimum of 3 years follow-up on a large
      number of subjects during use outside the constraints of a prescribed clinical study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The registry evaluates the MUSE System which creates a transoral anterior fundoplication for
      the treatment of GERD. The system enables the operator to staple the fundus of the stomach to
      the esophagus approximately 3cm superior to the Z-line in 2 or more locations. The procedure
      is performed transorally under general anesthesia. The procedural result is anatomically and
      functionally similar to standard anterior fundoplication (Dor-Thal operation). The staples
      are standard, 4.8mm titanium surgical staples. Each application of the device fires a
      quintuplet of staples (5) in three staggered rows. Anti-retching medications at the time of
      the procedure are essential.

      The study population will be primarily adults aged 18-70 years selected by the investigators
      based on SAGES guidelines for fundoplication and consideration of the indications and
      contraindications listed in the device Instructions for Use (IFU).

      Follow-up data will be collected at 6 months, 1, 2 and 3 years post procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Frequency of device and procedure related adverse events</measure>
    <time_frame>30 days post procedure</time_frame>
    <description>Device or procedure-related adverse events and serious adverse events will be evaluated for onset, frequency and duration. The primary safety assessment time point will be within 30 days of the procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure Durability</measure>
    <time_frame>Up to 3 years post procedure</time_frame>
    <description>Baseline and follow-up measurements of proton pump inhibitors use and GERD Health Related Quality of Life questionnaire will determine the proportion of patients with treatment success</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gastroesophageal Reflux Disease (GERD)</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medigus Ultrasonic Surgical Endostapler (MUSE) Procedure</intervention_name>
    <description>The procedure is performed transorally under general anesthesia. The physicians staples the fundus of the stomach to the esophagus approximately 3cm superior to the Z-line in 2 or more locations. The procedural result is anatomically and functionally similar to standard anterior fundoplication (Dor-Thal operation). The staples are standard, 4.8mm titanium surgical staples. Each application of the device fires a quintuplet of staples (5) in three staggered rows. Anti-retching medications at the time of the procedure are essential.</description>
    <other_name>Stapled anterior fundoplication</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The registry population will consist of adult subjects diagnosed with GERD who are deemed
        suitable for the procedure by the investigator given the information provided in the
        instructions for use.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Generally follow the guidelines for Laparoscopic Fundoplication published by SAGES (Society
        of American Gastrointestinal and Endoscopic Surgeons) Objective evidence of GERD

          -  Positive acid exposure test or endoscopic evidence of esophagitis AND

          -  Inadequate symptom control or

          -  Patient preference from surgery over medications or

          -  Extra-esophageal manifestations (asthma, hoarseness, cough, chest pain, aspiration)

        Exclusion Criteria:

          -  Significant co-morbidity (for example, American Society of Anesthesiologists Grade 3
             or higher)

          -  BMI &gt;35 or &lt;20

          -  No response to proton pump inhibitors

          -  Grade IV esophagitis

          -  Hiatal hernia &gt;3 cm

          -  Irreducible hernia of any size

          -  Gastric outlet obstruction

          -  Short esophagus

          -  Esophageal diverticula, strictures or varices

          -  Esophageal motility disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralf Kiesslich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director Klinik für Innere Medizin II; Dr. Horst Schmidt Klinik</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melina Salerno</last_name>
    <email>melina.salerno@medigus.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>UC Irvine Health</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuna Muyshondt, MPH</last_name>
      <phone>714-456-2215</phone>
      <email>chuny@uci.edu</email>
    </contact>
    <investigator>
      <last_name>Kenneth Chang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California at San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Lazar, MPH</last_name>
      <phone>619-471-0447</phone>
      <email>misresearch@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Santiago Horgan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Medical Center</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Draganov, MD</last_name>
      <phone>352-273-9472</phone>
      <email>peter.draganov@medicine.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Draganov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Borland Groover Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>904-680-0871</phone>
      <email>Research@borlandgrooverclinic.com</email>
    </contact>
    <investigator>
      <last_name>Ali Lankarani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose Nieto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gail McNulty, RN</last_name>
      <phone>317-948-3684</phone>
    </contact>
    <investigator>
      <last_name>Glen Lehman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ram Chuttani, MD</last_name>
      <phone>617-667-0162</phone>
      <email>vlsheppa@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Ram Chuttani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janna Mason</last_name>
      <phone>507-266-0516</phone>
      <email>janna.mason@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Barham Abu Dayyeh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Kollarus, BSN, RN</last_name>
      <phone>516-663-4652</phone>
      <email>mkollarus@winthrop.org</email>
    </contact>
    <investigator>
      <last_name>Stavros Stavropoulos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Poi Yu (Sofia) Yuen, MD</last_name>
      <phone>408-384-2038</phone>
      <email>pyuen2@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory Haber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony Starpoli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Dettorre</last_name>
      <email>Becky.Dettorre@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Kyle Perry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angielyn Rivera</last_name>
      <phone>713-486-1350</phone>
      <email>Angielyn.Rivera@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Shinil Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erik Wilson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kulvinder Bajwa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Walker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Düsseldorf, Medizinische Klinik</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Schneider, MD</last_name>
      <phone>0049-211-919-1605</phone>
      <email>Markus.Schneider@evk-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Horst Neuhaus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg</name>
      <address>
        <city>Ludwigsburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karel Caca, MD</last_name>
      <phone>0049 7141 9967201</phone>
      <email>karel.caca@kliniken-lb.de</email>
    </contact>
    <investigator>
      <last_name>Karel Caca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HSK, Dr. Horst Schmidt Kliniken GmbH</name>
      <address>
        <city>Wiesbaden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ralf Kiesslich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabrina Testoni</last_name>
      <phone>02.2643.2756</phone>
      <email>pieralberto.testoni@hsr.it</email>
    </contact>
    <investigator>
      <last_name>Pier Alberto Testoni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università Cattolica del Sacro Cuore Policlinico A. Gemelli</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolina Gualtieri</last_name>
      <phone>+39 (06) 35511515</phone>
      <email>c.gualtieri@eetc.it</email>
    </contact>
    <investigator>
      <last_name>Guido Costamagna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.medigus.com</url>
    <description>Study sponsor website</description>
  </link>
  <reference>
    <citation>Zacherl J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, Kessler WR, Selzer DJ, Broderick RC, Lehman GA, Horgan S. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015 Jan;29(1):220-9. doi: 10.1007/s00464-014-3731-3. Epub 2014 Aug 19.</citation>
    <PMID>25135443</PMID>
  </reference>
  <reference>
    <citation>Roy-Shapira A, Bapaye A, Date S, Pujari R, Dorwat S. Trans-oral anterior fundoplication: 5-year follow-up of pilot study. Surg Endosc. 2015 Dec;29(12):3717-21. doi: 10.1007/s00464-015-4142-9. Epub 2015 Mar 18.</citation>
    <PMID>25783833</PMID>
  </reference>
  <reference>
    <citation>Kim HJ, Kwon CI, Kessler WR, Selzer DJ, McNulty G, Bapaye A, Bonavina L, Lehman GA. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE™ endoscopic stapling device. Surg Endosc. 2016 Aug;30(8):3402-8. doi: 10.1007/s00464-015-4622-y. Epub 2015 Nov 4.</citation>
    <PMID>26537905</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2015</study_first_submitted>
  <study_first_submitted_qc>February 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2015</study_first_posted>
  <last_update_submitted>March 31, 2016</last_update_submitted>
  <last_update_submitted_qc>March 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

